CONTACT US: Contact info
|
Citation |
Hemwall EL. Clin. Pharmacol. Ther. 2010; 87(3): 267-269. |
|
Affiliation |
Worldwide OTC Regulatory and Scientific Affairs, Merck Research Laboratories, West Point, Pennsylvania, USA. |
|
Copyright |
(Copyright © 2010, American Society for Clinical Pharmacology and Therapeutics, Publisher Nature Publishing Group) |
|
DOI |
|
PMID |
20160746 |
|
Abstract |
As escalating health-care costs continue to be a focus of public discourse, the populace has become increasingly attentive to its own health and lifestyle choices. Nonprescription (over-the-counter, OTC) medicines represent an important option in this evolving environment and, through novel "Rx-to-OTC" switch efforts, could expand beyond their traditional role in symptomatic relief of common conditions such as minor pain, coughs, colds, heartburn, and allergy. This is certainly not a new concept. In fact, the self-care movement has roots reaching into the past century. Pharmaceutical companies and their consumer-product subsidiaries or partners have long considered and, when feasible, invested in difficult OTC switch development programs. Language: en |